3Hugenholtz J,Smid EJ.Nutraceutical production with foodgrade microorganisms[J].Curr Opin Biotechnol,2002,13:497-507.
4Teusink B,Smid EJ.Modelling strategies for the industrial exploitation of lactic acid bacteria[J].Nat Rev Microbiol,2006,(4):46-56.
5Jewett,M.C.,G.Hofmann,J.Nielsen.Fungal metabolite analysis in genomics and phenomics.Curr.Opin.Biotechnol,2006,17(2):191-197.
6Cindy D,Davis,Norman G.Hord.Nutritional "Omics" Technologies for Elucidating the Role(s) of Bioactive Food Components in Colon Cancer Prevention[J].J.Nutr.,2005,135:2694-26975.
7Zuercher AW,Miescher SM,Vogel M et al.,Oral anti-IgE immunization with epitope-displaying phage.Eur.J.Immunol.2000,30:128-135.
8Saxelin M,Tynkkynen S,Mattila-Sandholm T,et al.Probiotic and other functional microbes:from markets to mechanisms[J].Curr Opin Biotechnol,2005,16:204-211.
9Klaenhammer TR,Barrangou R,Buck BL,et al.Genomic features of lactic acid bacteria effecting bioprocessing and health[J].FEMS Microbiol Rev,2005,29:393-409.
10Marco Gallo,Johanna,Blacque et al.,Functional Genomics of the Cilium,a Sensory Organelle[J].Current Biology,2005,15:935-941.
